Vectus Biosystems (ASX:VBS) - Key People
ASX:VBS · Directors, executives and key personnel · 12 month lookback
Dr Karen Duggan
Current
Executive Director and Chief Executive Officer
No articles mention this person in the last 12 months.
Dr Ronald Shnier
Current
Non‑Executive Chairman (acting de facto as senior executive following CEO’s passing)
Mentioned in
Healthcare Wrap - Week 38 (14 Sept -> 18 Sept) 2026
19 Sept 2026
Vectus Turns XORTX Deal Into $1.56m Profit as VB0004 Moves Toward Phase Ib
18 Sept 2026
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Vectus Secures Cardinal Health for US FDA Pathway on VB0004
13 July 2026
Mentioned in
Healthcare Wrap - Week 38 (14 Sept -> 18 Sept) 2026
19 Sept 2026
Vectus Turns XORTX Deal Into $1.56m Profit as VB0004 Moves Toward Phase Ib
18 Sept 2026
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Vectus Secures Cardinal Health for US FDA Pathway on VB0004
13 July 2026
Also Mentioned
People named in Vectus Biosystems (ASX:VBS) articles over the last 12 months, by frequency.
Robert Waring
· 8 articles
Ron Shnier
· 8 articles
Maurie Stang
· 5 articles
Linda Walters
· 4 articles
Tara Speranza, CEO and CTO
· 2 articles
Ronald Shnier, Chairman
· 2 articles
Matthew Pope
· 2 articles
Mark Nicholaeff
· 2 articles
Martina Molsbergen
· 1 article
R Hutchens
· 1 article